Back to the Bench: Exploring the Potential of CAR T-Cell Therapy in Oncology

News
Video

Miguel-Angel Perales, MD, and Caron A. Jacobson, MD, share insights regarding the context and implications of the recent actions by the FDA to add boxed warnings to CAR T-cell therapies.

Recent Videos
Ben Samelson-Jones, MD, PhD, assistant professor pediatric hematology, Perelman School of Medicine, University of Pennsylvania and Associate Director, Clinical In Vivo Gene Therapy, Children’s Hospital of Philadelphia
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Steven W. Pipe, MD, a professor of pediatric hematology/oncology at CS Mott Children’s Hospital
Haydar Frangoul, MD, the medical director of pediatric hematology/oncology at Sarah Cannon Research Institute and Pediatric Transplant and Cellular Therapy Program at TriStar Centennial
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Chun-Yu Chen, PhD, a research scientist at Seattle Children’s Research Institute
Michael Severino on In Vivo Gene Editing With RNA Gene Writers
Chris Wright, MD, PhD, on Annelloviruses, a Potential Alternative to AAV for Gene Therapy
Carol Miao, PhD, a principal investigator at Seattle Children’s Research Institute
Related Content
First Patient With Multiple Myeloma Dosed in EsoBiotec's Trial for In Vivo CAR-T ESO-T01

First Patient With Multiple Myeloma Dosed in EsoBiotec's Trial for In Vivo CAR-T ESO-T01

Noah Stansfield
January 9th 2025
Article

According to EsoBiotec, this is the first time a patient has been treated with an in vivo BCMA-directed CAR-T therapy in a clinical trial.

ImmunoLogic

CGTLive® Presents: ImmunoLogic, A Video Podcast With Joseph Fraietta, PhD

Joseph A. Fraietta, PhD;Noah Stansfield;Matt Hoffman
December 18th 2024
Podcast

Hosted by Joseph Fraietta, PhD, ImmunoLogic will be tailored for an audience fluent in the language of medicine and biotechnology, offering data-driven insights while maintaining accessibility.

Data Roundup: December 2024 Features Updates for Cilta-Cel in Multiple Myeloma, mRNA CAR-T in Myasthenia Gravis, and More

Data Roundup: December 2024 Features Updates for Cilta-Cel in Multiple Myeloma, mRNA CAR-T in Myasthenia Gravis, and More

CGTLive Staff
January 6th 2025
Article

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

FDA Activity Recap: December 2024 Features New Approval, a Clinical Hold, and More

FDA Activity Recap: December 2024 Features New Approval, a Clinical Hold, and More

CGTLive Staff
January 5th 2025
Article

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – January 3, 2025

CGTLive Staff
January 3rd 2025
Article

Review top news and interview highlights from the weeks ending December 27, 2024, and January 3, 2025.

CGTLive's 2024 Pillars of Progress: Top News in Hematology

CGTLive's 2024 Pillars of Progress: Top News in Hematology

CGTLive Staff
December 31st 2024
Article

Take a look what stood out as pillars of progress and success from all of CGTLive's most popular hematology stories in 2024.

© 2025 MJH Life Sciences

All rights reserved.